Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS‐PC study

We previously conducted a phase I clinical trial combining the HLA‐A*2402‐restricted KIF20A‐derived peptide vaccine with gemcitabine for advanced pancreatic cancer (PC) and confirmed its safety and immunogenicity in cancer patients. In this study, we conducted a multicenter, single‐armed, phase II t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Suzuki, Nobuaki, Hazama, Shoichi, Iguchi, Haruo, Uesugi, Kazuhiro, Tanaka, Hiroaki, Hirakawa, Kosei, Aruga, Atsushi, Hatori, Takashi, Ishizaki, Hidenobu, Umeda, Yuzo, Fujiwara, Toshiyoshi, Ikemoto, Tetsuya, Shimada, Mitsuo, Yoshimatsu, Kazuhiko, Shimizu, Ryoichi, Hayashi, Hiroto, Sakata, Koichiro, Takenouchi, Hiroko, Matsui, Hiroto, Shindo, Yoshitaro, Iida, Michihisa, Koki, Yasunobu, Arima, Hideki, Furukawa, Hiroyuki, Ueno, Tomio, Yoshino, Shigefumi, Nakamura, Yusuke, Oka, Masaaki, Nagano, Hiroaki
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5276830/
https://ncbi.nlm.nih.gov/pubmed/27783849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados